Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;64(8):979-988.
doi: 10.1111/dmcn.15176. Epub 2022 Feb 14.

Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy

Collaborators, Affiliations

Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy

Alberto A Zambon et al. Dev Med Child Neurol. 2022 Aug.

Abstract

Aim: To correlate the North Star Ambulatory Assessment (NSAA) and timed rise from floor (TRF) recorded at age of expected peak with age at loss of ambulation (LOA) in Duchenne muscular dystrophy (DMD).

Method: Male children with DMD enrolled in the UK North Start Network database were included according to the following criteria: follow-up longer than 3 years, one NSAA record between 6 years and 7 years 6 months (baseline), at least one visit when older than 8 years. Data about corticosteroid treatment, LOA, genotype, NSAA, and TRF were analysed. Age at LOA among the different groups based on NSAA and TRF was determined by log-rank tests. Cox proportional hazard models were used for multivariable analysis.

Results: A total of 293 patients from 13 different centres were included. Mean (SD) age at first and last visit was 5 years 6 months (1 year 2 months) and 12 years 8 months (2 years 11 months) (median follow-up 7 years 4 months). Higher NSAA and lower TRF at baseline were associated with older age at LOA (p<0.001). Patients scoring NSAA 32 to 34 had a probability of 0.61 of being ambulant when older than 13 years compared with 0.34 for those scoring 26 to 31. In multivariable analysis, NSAA, TRF, and corticosteroid daily regimen (vs intermittent) were all independently associated with outcome (p=0.01).

Interpretation: Higher functional abilities at peak are associated with older age at LOA in DMD. This information is important for counselling families. These baseline measures should also be considered when designing clinical trials.

PubMed Disclaimer

Figures

GURE 1
GURE 1
(a) Frequency of North Star Ambulatory Assessment (NSAA) scores at baseline. (b) Correlation between NSAA and timed rise from floor (TRF) at baseline. (c) Correlation between corticosteroid dose/regimen and NSAA score at baseline
FIGURE 2
FIGURE 2
Kaplan–Meier curves showing time to loss of ambulation (LOA) according to (a) North Star Ambulatory Assessment (NSAA) group and (b) timed rise from floor (TRF)

References

    1. Emery AE. Population frequencies of inherited neuromuscular diseases–a world survey. Neuromuscular Disorders: NMD. 1991;1:19–29. - PubMed
    1. Mendell JR, Shilling C, Leslie ND, Flanigan KM, al‐Dahhak R, Gastier‐Foster J, et al. Evidence‐based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012;71:304–13. - PubMed
    1. Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifirò G. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta‐analysis. Orphanet J Rare Dis. 2020;15:141. - PMC - PubMed
    1. Mercuri E, Coratti G, Messina S, Ricotti V, Baranello G, D’Amico A, et al. Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy. PLoS One. 2016;11:e0160195. - PMC - PubMed
    1. Ricotti V, Ridout DA, Pane M, Main M, Mayhew A, Mercuri E, Manzur AY, Muntoni F. The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials. J Neurol Neurosurg Psychiatry. 2016;87:149–55. - PMC - PubMed

Publication types

Substances